Next Article in Journal
Assessing Drug–Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption
Next Article in Special Issue
Clinical Applications of Targeted Nanomaterials
Previous Article in Journal
Special Issue “Pharmaceutical Solid Forms: From Crystal Structure to Formulation”
Previous Article in Special Issue
Curcumin Microemulsions: Influence of Compositions on the Dermal Penetration Efficacy
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(3), 313; https://doi.org/10.3390/pharmaceutics17030313
Action Date Notes Link
article pdf uploaded. 28 February 2025 16:48 CET Version of Record https://www.mdpi.com/1999-4923/17/3/313/pdf-vor
article xml file uploaded 3 March 2025 06:51 CET Original file -
article xml uploaded. 3 March 2025 06:51 CET Update -
article pdf uploaded. 3 March 2025 06:51 CET Updated version of record https://www.mdpi.com/1999-4923/17/3/313/pdf-vor
article html file updated 3 March 2025 06:52 CET Original file -
article xml file uploaded 3 March 2025 07:17 CET Update -
article xml uploaded. 3 March 2025 07:17 CET Update https://www.mdpi.com/1999-4923/17/3/313/xml
article pdf uploaded. 3 March 2025 07:17 CET Updated version of record https://www.mdpi.com/1999-4923/17/3/313/pdf
article html file updated 3 March 2025 07:19 CET Update -
article html file updated 3 March 2025 11:50 CET Update https://www.mdpi.com/1999-4923/17/3/313/html
Back to TopTop